Special population studies, including evaluation in elderly patients, patients with significant comorbidities, and patients with organ dysfunction, would help establish safety profiles for diverse clinical populations
Yes Clinical urgency supports starting treatment now rather than waiting for policy changes No Consider whether waiting 12-24 months for potential provincial coverage expansion is reasonable Decision point 5: Are you comfortable with manual injection from a vial
Just pure H2O sterilized through filtration or heat
Begin Your Journey with Ongoing Support: Youll have regular check-ins with your provider and unlimited access to your wellness coach through the Claya app
Reduced atherogenesis: Some research suggests GLP-1 medications may slow the development of arterial plaques
This is not definitive evidence, as many factors affect treatment outcomes, but it can serve as a useful signal when interpreted alongside other information about your storage practices